Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Innventure, Inc. Regulatory Filings 2024

Dec 18, 2024

33263_prs_2024-12-18_43d9daf9-bc8e-4c24-97f7-4e825c912d3e.zip

Regulatory Filings

Open in viewer

Opens in your device viewer

424B3 1 prospectussupplementno6fora.htm 424B3 Document created using Wdesk Copyright 2024 Workiva Prospectus Supplement No. 6 (Form 8-K - Dec 18, 2024) - S-1

Filed pursuant to Rule 424(b)(3)

Registration No. 333-282971

Prospectus Supplement No. 6

(To Prospectus dated November 12, 2024)

INNVENTURE, INC.

This prospectus supplement updates, amends and supplements the prospectus dated November 12, 2024 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-282971) and is being filed to update, amend and supplement the information included in the Prospectus with information contained in our Current Report on Form 8-K , which was filed with the Securities and Exchange Commission (the “SEC”) on December 18, 2024 (the “Current Report”). Accordingly, we have attached the Current Report to this prospectus supplement. Capitalized terms used in this prospectus supplement and not otherwise defined herein have the meanings specified in the Prospectus.

This prospectus supplement is not complete without the Prospectus. This prospectus supplement should be read in conjunction with the Prospectus, which is to be delivered with this prospectus supplement, and is qualified by reference thereto, except to the extent that the information in this prospectus supplement updates or supersedes the information contained in the Prospectus. Please keep this prospectus supplement with your Prospectus for future reference.

Shares of our common stock, par value $0.0001 per share (our “Common Stock”), are listed on The Nasdaq Stock Market, LLC under the symbol “INV.” On December 17, 2024, the closing price of our Common Stock was $12.79 per share.

Investing in our securities involves risks that are described in the “Ri sk Factors” section of the Prospectus.

Neither the SEC nor any state securities commission has approved or disapproved of the securities to be issued under the Prospectus or this prospectus supplement or determined if the Prospectus or this prospectus supplement is truthful or complete. Any representation to the contrary is a criminal offense.

The date of this prospectus supplement is December 18, 2024.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_____

FORM 8-K

_____

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

December 18, 2024

Date of Report (date of earliest event reported)

_____

Innventure, Inc.

(Exact name of registrant as specified in its charter)

_____

Delaware (State or other jurisdiction of incorporation or organization)
6900 Tavistock Lakes Blvd, Suite 400 Orlando, Florida 32827
(Address of principal executive offices and zip code)
(321) 209-6787
(Registrant's telephone number, including area code)

_____

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: — Title of each class Trading Symbol Name of each exchange on which registered
Common Stock, par value $0.0001 per share INV The Nasdaq Stock Market, LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 12b-2 of the Exchange Act.

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01 - Regulation FD Disclosure

On December 18, 2024, Innventure, Inc. issued a press release, attached hereto as Exhibit 99.1 and incorporated herein by reference, announcing its plan to collaborate with The Dow Chemical Company on a waste-to-value platform and the launch of Refinity, a new majority-owned subsidiary, that intends to commercialize waste-to-value technologies.

Item 9.01 Financial Statements and Exhibits .

(d) Exhibits

Exhibit Number Description of Exhibit
99.1 Press Release by Innventure, Inc. dated December 18, 2024
104 Cover Page Interactive Data File (formatted in Inline XBRL)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

INNVENTURE, INC. — By: /s/ David Yablunosky
Name: David Yablunosky
Title: Chief Financial Officer